Averna's Matt Thompson shares strategies to avoid common traps when transitioning medical devices from R&D to manufacturing.
Enzymit's cell-free process is the first to let manufacturers set the size of hyaluronic acid during production. Using the same enzymatic process, it can make HA in defined sizes from about 10 kDa to ...
Researchers have developed an innovative and versatile system designed for a new generation of short-pulse lasers. Lasers ...
“Our diligence process was deliberate and comprehensive,” added Corkum. “We wanted an American manufacturing partnership that reflects our core values—integrity, quality, and accountability. As we ...
Doseology Sciences ( ($TSE:MOOD) ) has issued an announcement. Doseology Sciences Inc. has announced a significant milestone with its subsidiary, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results